Evidence map›Paper›PMID 25740934›Full record

ArticleG3 (Bethesda, Md.)2015

Genetic Analysis of Substrain Divergence in Non-Obese Diabetic (NOD) Mice.

Petr Simecek, Gary A Churchill, Hyuna Yang, Lucy B Rowe, Lieselotte Herberg, David V Serreze, Edward H Leiter

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Advancing Animal Models of Human Type 1 Diabetes.Cold Spring Harbor perspectives in medicine · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. De novo germline mutation in the dual specificity phosphatase 10 gene accelerates autoimmune diabetes.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  9. Article
  10. T Cells from NOD-Journal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Petr SimecekThe Jackson Laboratory, Bar Harbor, Maine 04609 petrs@jax.org.ORCID http://orcid.org/0000-0002-2922-7183
Gary A ChurchillThe Jackson Laboratory, Bar Harbor, Maine 04609.
Hyuna YangExploratory Statistics, DSS, AbbVie, North Chicago, Illinois 60064.
Lucy B RoweThe Jackson Laboratory, Bar Harbor, Maine 04609.
Lieselotte HerbergDiabetes Research Institute, Düsseldorf, Germany.
David V SerrezeThe Jackson Laboratory, Bar Harbor, Maine 04609.
Edward H LeiterThe Jackson Laboratory, Bar Harbor, Maine 04609.
Jackson Laboratory · USAbbVie (United States) · USDeutsches Diabetes-Zentrum e.V. · DE

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
UNC and PERLEGEN, IncP50GM076468 · NIGMS · JACKSON LABORATORY · PI CHESLER, ELISSA J · 2006 to 2015
$31.0M
The Jackson Laboratory Center for Precision Genetics: From New Models to Novel TherapeuticsU54OD020351 · OD · JACKSON LABORATORY · PI BURGESS, ROBERT W. · 2015 to 2019
$10.2M
Diabetogenic Role of MHC Class I Alleles in NOD MiceR01DK046266 · NIDDK · JACKSON LABORATORY · PI SERREZE, DAVID V · 2000 to 2018
$7.2M
B-lymphocyte Targeting Therapies for Autoimmune DiabetesR01DK095735 · NIDDK · JACKSON LABORATORY · PI SERREZE, DAVID V · 2013 to 2025
$6.2M
Type 1 Diabetes Mouse Resource (T1DR)UC4DK097610 · NIDDK · JACKSON LABORATORY · PI SERREZE, DAVID V · 2012 to 2012
$2.5M
DIABETOGENIC ROLE OF H-2G7 CLASS I ALLELES IN NOD MICER29DK046266 · NIDDK · JACKSON LABORATORY · PI SERREZE, DAVID V. · 1993 to 1998
–
NCI NIH HHS P30 CA034196NCI NIH HHS P30CA034196NIDDK NIH HHS DK046266NIDDK NIH HHS DK095735NIDDK NIH HHS R01 DK046266NIDDK NIH HHS R01 DK095735NIDDK NIH HHS R29 DK046266NIDDK NIH HHS UC4 DK097610NIDDK NIH HHS UC4-DK097610NIGMS NIH HHS P50 GM076468NIGMS NIH HHS P50GM076468NIH HHS U54 OD020351
6 · The paper itself

Abstract

The non-obese diabetic (NOD) mouse is a polygenic model for type 1 diabetes that is characterized by insulitis, a leukocytic infiltration of the pancreatic islets. During ~35 years since the original inbred strain was developed in Japan, NOD substrains have been established at different laboratories around the world. Although environmental differences among NOD colonies capable of impacting diabetes incidence have been recognized, differences arising from genetic divergence have not been analyzed previously. We use both mouse diversity array and whole-exome capture sequencing platforms to identify genetic differences distinguishing five NOD substrains. We describe 64 single-nucleotide polymorphisms, and two short indels that differ in coding regions of the five NOD substrains. A 100-kb deletion on Chromosome 3 distinguishes NOD/ShiLtJ and NOD/ShiLtDvs from three other substrains, whereas a 111-kb deletion in the Icam2 gene on Chromosome 11 is unique to the NOD/ShiLtDvs genome. The extent of genetic divergence for NOD substrains is compared with similar studies for C57BL6 and BALB/c substrains. As mutations are fixed to homozygosity by continued inbreeding, significant differences in substrain phenotypes are to be expected. These results emphasize the importance of using embryo freezing methods to minimize genetic drift within substrains and of applying appropriate genetic nomenclature to permit substrain recognition when one is used.

Indexed as

Genetic VariationAnimalsExomeFemaleGenomeHigh-Throughput Nucleotide SequencingINDEL MutationMaleMiceMice, Inbred NODPhylogenyPolymorphism, Single Nucleotideexome captureIcam2NOD micesubstrain divergencetype 1 diabetes

Identifiers

PMID25740934
PMCPMC4426365
OpenAlexW2949200006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.